Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis

CONCLUSION: Secukinumab showed long-term effectiveness across the six key PsA domains thus reducing disease activity and pain, which are major treatment goals. This was accompanied by high persistence rates, especially in bDMARD naive patients.PMID:38053615 | PMC:PMC10694458 | DOI:10.3389/fmed.2023.1294247
Source: Pain Physician - Category: Anesthesiology Authors: Source Type: research